Home
>
National Drug Code (NDC)
>
Flanax Pain Reliever
Flanax Pain Reliever - 27854-103-01 - (Naproxen Sodium)
Drug Information of Flanax Pain Reliever
| Product NDC: | 27854-103 |
| Proprietary Name: | Flanax Pain Reliever |
| Non Proprietary Name: | Naproxen Sodium |
| Active Ingredient(s): | 220 mg/1 & nbsp; Naproxen Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Flanax Pain Reliever
| Product NDC: | 27854-103 |
| Labeler Name: | Belmora LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA079096 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121206 |
Package Information of Flanax Pain Reliever
| Package NDC: | 27854-103-01 |
| Package Description: | 24 TABLET in 1 BOTTLE (27854-103-01) |
NDC Information of Flanax Pain Reliever
| NDC Code | 27854-103-01 |
| Proprietary Name | Flanax Pain Reliever |
| Package Description | 24 TABLET in 1 BOTTLE (27854-103-01) |
| Product NDC | 27854-103 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Naproxen Sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20121206 |
| Marketing Category Name | ANDA |
| Labeler Name | Belmora LLC |
| Substance Name | NAPROXEN SODIUM |
| Strength Number | 220 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
